Gossamer Bio, Inc. (GOSS:NASDAQ) closed at $10.47 on November 17, 2026, down 4.64% on the day. The stock trades 96.6% below its 52-week high of $309.60 and 26.3% above its 52-week low of $8.29. Over the past year, it lost 95.4%. Gossamer Bio, Inc. is part of the Health Care sector (Major Pharmaceuticals).
In 252 trading sessions since November 14, 2025, GOSS closed higher on 114 days (45%). Its best day was July 27, 2026 (+46.32%) and its worst was February 23, 2026 (-80.14%). The stock moved 10% or more in a single session 28 times. It opened at least 5% above the previous day's high 4 times.
Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, acquiring, developing and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. Its pipeline products include GB001 (DP2 Antagonist), GB002 (PDGF Receptor Kinase Inhibitor), GB004 (HIF-1a Stabilizer), and others.
Find more stocks like GOSS with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.